Combining Ixazomib With Subcutaneous Rituximab and Dexamethasone in Relapsed or Refractory Waldenström's Macroglobulinemia: Final Analysis of the Phase I/II HOVON124/ECWM-R2 Study

Marie José Kersten, Karima Amaador, Monique C. Minnema, Josephine M.I. Vos, Kazem Nasserinejad, Marcel Kap, Efstathios Kastritis, Maria Gavriatopoulou, Willem Kraan, Martine E.D. Chamuleau, Dries Deeren, Lidwine W. Tick, Jeanette K. Doorduijn, Fritz Offner, Lara H. Böhmer, Roberto D. Liu, Steven T. Pals, Meletios A. Dimopoulos

Research output: Contribution to journalArticleAcademicpeer-review

13 Citations (Scopus)
9 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Combining Ixazomib With Subcutaneous Rituximab and Dexamethasone in Relapsed or Refractory Waldenström's Macroglobulinemia: Final Analysis of the Phase I/II HOVON124/ECWM-R2 Study'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science